Contact
C8 L-threo-Lactosyl(ß) Ceramide (d18:1/8:0)

C8 L-threo-Lactosyl(ß) Ceramide (d18:1/8:0) A86575 (Previously 860575) D-lactosyl-ß1-1'-N-octanoyl-L-threo-sphingosine

C8 L-threo-Lactosyl(ß) Ceramide (d18:1/8:0)

β-D-lactosyl-N-octanoyl-L-threo-sphingosine, (1) selectively inhibits caveolar endocytosis and SV40 virus infection, (2) blocks the clustering of lipids and proteins into GSLs and cholesterol-enriched microdomains (rafts) at the PM, and (3) inhibits β1-integrin activation and downstream signaling. Singh, R.D., E.L. Holicky, Z.J. Cheng, S.Y. Kim, C.L. Wheatley, D.L. Marks, R. Bittman, and R.E. Pagano. (2007). Inhibition of caveolar uptake, SV40 infection, and β1-integrin signaling by a nonnatural glycosphingolipid stereoisomer. J Cell Biol 176:895-901.

00000000
$0.00
Buy
Please confirm your location

Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate location button below.

For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!

*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada